[DPHARMA] YoY Annualized Quarter Result on 30-Jun-2013 [#2]

Announcement Date
28-Aug-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2013
Quarter
30-Jun-2013 [#2]
Profit Trend
QoQ- 29.78%
YoY- 28.09%
Quarter Report
View:
Show?
Annualized Quarter Result
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
Revenue 317,210 203,814 162,236 151,652 140,824 136,658 129,554 16.07%
PBT 35,328 41,210 42,604 43,926 35,812 34,332 33,164 1.05%
Tax -11,790 -11,576 -10,820 -9,150 -8,662 -8,620 -8,292 6.03%
NP 23,538 29,634 31,784 34,776 27,150 25,712 24,872 -0.91%
-
NP to SH 24,692 29,634 31,784 34,776 27,150 25,712 24,872 -0.12%
-
Tax Rate 33.37% 28.09% 25.40% 20.83% 24.19% 25.11% 25.00% -
Total Cost 293,672 174,180 130,452 116,876 113,674 110,946 104,682 18.73%
-
Net Worth 446,334 190,284 179,045 187,340 162,400 154,105 140,182 21.26%
Dividend
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
Div 13,947 11,193 11,103 11,101 9,716 9,718 12,491 1.85%
Div Payout % 56.49% 37.77% 34.93% 31.92% 35.79% 37.80% 50.22% -
Equity
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
Net Worth 446,334 190,284 179,045 187,340 162,400 154,105 140,182 21.26%
NOSH 278,959 139,915 138,794 138,770 138,803 138,833 138,794 12.32%
Ratio Analysis
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
NP Margin 7.42% 14.54% 19.59% 22.93% 19.28% 18.81% 19.20% -
ROE 5.53% 15.57% 17.75% 18.56% 16.72% 16.68% 17.74% -
Per Share
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
RPS 113.71 145.67 116.89 109.28 101.46 98.43 93.34 3.34%
EPS 8.44 21.18 22.90 25.06 19.56 18.52 17.92 -11.78%
DPS 5.00 8.00 8.00 8.00 7.00 7.00 9.00 -9.32%
NAPS 1.60 1.36 1.29 1.35 1.17 1.11 1.01 7.96%
Adjusted Per Share Value based on latest NOSH - 138,818
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
RPS 32.98 21.19 16.87 15.77 14.64 14.21 13.47 16.07%
EPS 2.57 3.08 3.30 3.62 2.82 2.67 2.59 -0.12%
DPS 1.45 1.16 1.15 1.15 1.01 1.01 1.30 1.83%
NAPS 0.464 0.1978 0.1861 0.1948 0.1688 0.1602 0.1457 21.27%
Price Multiplier on Financial Quarter End Date
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
Date 30/06/16 30/06/15 30/06/14 28/06/13 29/06/12 30/06/11 30/06/10 -
Price 2.04 2.65 2.97 2.38 2.23 2.34 2.45 -
P/RPS 1.79 1.82 2.54 2.18 2.20 2.38 2.62 -6.14%
P/EPS 23.05 12.51 12.97 9.50 11.40 12.63 13.67 9.08%
EY 4.34 7.99 7.71 10.53 8.77 7.91 7.31 -8.31%
DY 2.45 3.02 2.69 3.36 3.14 2.99 3.67 -6.50%
P/NAPS 1.28 1.95 2.30 1.76 1.91 2.11 2.43 -10.12%
Price Multiplier on Announcement Date
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
Date 22/08/16 25/08/15 26/08/14 28/08/13 16/08/12 18/08/11 24/08/10 -
Price 2.14 2.40 3.37 2.44 2.38 2.22 2.45 -
P/RPS 1.88 1.65 2.88 2.23 2.35 2.26 2.62 -5.37%
P/EPS 24.18 11.33 14.72 9.74 12.17 11.99 13.67 9.96%
EY 4.14 8.83 6.80 10.27 8.22 8.34 7.31 -9.03%
DY 2.34 3.33 2.37 3.28 2.94 3.15 3.67 -7.21%
P/NAPS 1.34 1.76 2.61 1.81 2.03 2.00 2.43 -9.43%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment